TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PEPTONIC medical AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
37,602
|
41,274
|
30,859 |
Financial expenses |
2,353
|
5,263
|
70 |
Earnings before taxes |
-43,144
|
-34,864
|
-71,862 |
EBITDA |
-35,375
|
-28,486
|
-45,507 |
Total assets |
108,127
|
81,114
|
81,431 |
Current assets |
40,942
|
29,658
|
26,415 |
Current liabilities |
31,822
|
33,168
|
30,703 |
Equity capital |
76,305
|
44,545
|
50,728 |
- share capital |
38,871
|
22,961
|
18,689 |
Employees (average) |
37
|
33
|
34 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
70.6%
|
54.9%
|
62.3% |
Turnover per employee |
1,016
|
1,251
|
908 |
Profit as a percentage of turnover |
-114.7%
|
-84.5%
|
-232.9% |
Return on assets (ROA) |
-37.7%
|
-36.5%
|
-88.2% |
Current ratio |
128.7%
|
89.4%
|
86.0% |
Return on equity (ROE) |
-56.5%
|
-78.3%
|
-141.7% |
Change turnover |
-6,601
|
11,342
|
10,103 |
Change turnover % |
-15%
|
38%
|
49% |
Chg. No. of employees |
4
|
-1
|
15 |
Chg. No. of employees % |
12%
|
-3%
|
79% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.